Evommune, Inc. (EVMN) — Long-term Investment Intensity

Latest as of December 2025: 30.0%

Evommune, Inc. (EVMN) has a Long-term Investment Intensity of 30.0% as of December 2025. Long-term investments of $67.49 Million represent 30.0% of total assets of $224.95 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Evommune, Inc. book value and equity for net asset value and shareholders' equity analysis.

LT Investment Intensity

30.0%
LT Investments / Total Assets

Long-term Investments

$67.49 Million
USD

Total Assets

$224.95 Million
USD

Country

USA
NYSE

Evommune, Inc. Long-term Investment Intensity (2025–2025)

This chart shows how Evommune, Inc.'s Long-term Investment Intensity has evolved across 1 annual periods from 2025 to 2025. As of December 2025, the intensity stands at 30.0%, reflecting long-term investments of $67.49 Million against total assets of $224.95 Million USD. Also explore Evommune, Inc. asset portfolio for the complete picture of this company's asset base.

Annual Long-term Investment Intensity for Evommune, Inc. (2025–2025)

The table below presents the year-by-year Long-term Investment Intensity for Evommune, Inc. from 2025 to 2025, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see EVMN company net worth.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2025 30.0% $67.49 Million $224.95 Million
pp = percentage points